Ameritas Investment Partners’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1K | Hold |
7,514
| – | – | ﹤0.01% | 2525 |
|
|
2025
Q1 | $22.5K | Hold |
7,514
| – | – | ﹤0.01% | 2500 |
|
|
2024
Q4 | $25.2K | Hold |
7,514
| – | – | ﹤0.01% | 2535 |
|
|
2024
Q3 | $25.2K | Hold |
7,514
| – | – | ﹤0.01% | 2539 |
|
|
2024
Q2 | $24.9K | Hold |
7,514
| – | – | ﹤0.01% | 2522 |
|
|
2024
Q1 | $30.4K | Hold |
7,514
| – | – | ﹤0.01% | 2402 |
|
|
2023
Q4 | $22.9K | Buy |
7,514
+2,450
| +48% | +$7.47K | ﹤0.01% | 2523 |
|
|
2023
Q3 | $15.2K | Hold |
5,064
| – | – | ﹤0.01% | 2660 |
|
|
2023
Q2 | $18.9K | Hold |
5,064
| – | – | ﹤0.01% | 2593 |
|
|
2023
Q1 | $17K | Hold |
5,064
| – | – | ﹤0.01% | 2530 |
|
|
2022
Q4 | $24.1K | Hold |
5,064
| – | – | ﹤0.01% | 2487 |
|
|
2022
Q3 | $28K | Hold |
5,064
| – | – | ﹤0.01% | 2336 |
|
|
2022
Q2 | $35K | Hold |
5,064
| – | – | ﹤0.01% | 2214 |
|
|
2022
Q1 | $37K | Hold |
5,064
| – | – | ﹤0.01% | 2233 |
|
|
2021
Q4 | $45K | Hold |
5,064
| – | – | ﹤0.01% | 2186 |
|
|
2021
Q3 | $178K | Hold |
5,064
| – | – | 0.01% | 1290 |
|
|
2021
Q2 | $109K | Buy |
5,064
+3,849
| +317% | +$82.8K | ﹤0.01% | 1674 |
|
|
2021
Q1 | $75K | Hold |
1,215
| – | – | ﹤0.01% | 1828 |
|
|
2020
Q4 | $51K | Buy |
+1,215
| New | +$51K | ﹤0.01% | 1979 |
|